-
-
-
-
-
-
-
Maravai LifeSciences (MRVI) Tops Q4 EPS by 3c ; Offers Guidance
-
-
-
-
-
-
-
Maravai LifeSciences Reports Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
Maravai LifeSciences (MRVI) Misses Q1 EPS by 1c, provides guidance
-
-
-
-
-
-
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
-
-
-
-
-
-
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
-
-
-
-
-
-
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
-
-
-
-
-
-
-
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
-
1,219,416 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

